chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced MYALGIA (Soreness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at a dose of 1 dosage form. On 27-Apr-2021, MYALGIA (Soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-207618 (Patient Link).
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Lymphadenopathy
Clinical narrative: small patch on lower back that become worse,was diagnosed for shingles; swollen right groin lymph node; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (small patch on lower back that become worse,was diagnosed for shingles) and LYMPHADENOPATHY (swollen right groin lymph node) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced HERPES ZOSTER (small patch on lower back that become worse,was diagnosed for shingles) and LYMPHADENOPATHY (swollen right groin lymph node). The patient was treated with FAMCICLOVIR for Shingles, at a dose of 5mg and TEMAZEPAM at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (small patch on lower back that become worse,was diagnosed for shingles) had not resolved and LYMPHADENOPATHY (swollen right groin lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: Sleepy after the 1st dose; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (Sleepy after the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, VITAMINS NOS for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, the patient experienced SOMNOLENCE (Sleepy after the 1st dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 29-Apr-2021, SOMNOLENCE (Sleepy after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also took hydration drink for treatment.
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction
Clinical narrative: adverse effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (adverse effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (adverse effect). At the time of the report, ADVERSE REACTION (adverse effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vomiting
Clinical narrative: Fever of 102.after the 2nd dose; Have been throwing up after the 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102.after the 2nd dose) and VOMITING (Have been throwing up after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 102.after the 2nd dose) and VOMITING (Have been throwing up after the 2nd dose). At the time of the report, PYREXIA (Fever of 102.after the 2nd dose) and VOMITING (Have been throwing up after the 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102.         No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Eye pain, Lacrimation increased, Ocular discomfort, Pain in extremity
Clinical narrative: Sore left eye after the 2nd dose; Both eyes are watery and tired that she can't keep them opened after the 2nd dose; Eyes are weird and not normal after the 2nd dose; Right ear from the outside tender and not painful after the 2nd dose; Sore arm after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after the 2nd dose), EYE PAIN (Sore left eye after the 2nd dose), LACRIMATION INCREASED (Both eyes are watery and tired that she can't keep them opened after the 2nd dose), OCULAR DISCOMFORT (Eyes are weird and not normal after the 2nd dose) and EAR DISCOMFORT (Right ear from the outside tender and not painful after the 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014C21A and 044B21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, VITAMINS NOS for an unknown indication.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced PAIN IN EXTREMITY (Sore arm after the 2nd dose). On 03-Jun-2021, the patient experienced EYE PAIN (Sore left eye after the 2nd dose), LACRIMATION INCREASED (Both eyes are watery and tired that she can't keep them opened after the 2nd dose), OCULAR DISCOMFORT (Eyes are weird and not normal after the 2nd dose) and EAR DISCOMFORT (Right ear from the outside tender and not painful after the 2nd dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 03-Jun-2021, EAR DISCOMFORT (Right ear from the outside tender and not painful after the 2nd dose) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm after the 2nd dose), EYE PAIN (Sore left eye after the 2nd dose), LACRIMATION INCREASED (Both eyes are watery and tired that she can't keep them opened after the 2nd dose) and OCULAR DISCOMFORT (Eyes are weird and not normal after the 2nd dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient took  hydration drinks as a treatment medications. Expiration dates for both doses are unknown.   This case was linked to MOD-2021-207611 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abscess, Induration, Peripheral swelling, Pyrexia, Vaccination site pruritus
Clinical narrative: Hard at top of the arm; Round welch; Swollen top of the arm; itching really bad at the site/Slight itchy after day 1; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (Hard at top of the arm), ABSCESS (Round welch), PERIPHERAL SWELLING (Swollen top of the arm), VACCINATION SITE PRURITUS (itching really bad at the site/Slight itchy after day 1) and PYREXIA (Fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     Concurrent medical conditions included Inflammation, Drug allergy (Septra), Allergy to antibiotic (Erythromycin), Drug allergy (Vicodin) and Drug allergy (Clindamycin). Concomitant products included FISH OIL, CURCUMA LONGA RHIZOME (TURMERIC CURCUMIN [CURCUMA LONGA RHIZOME]) and CHONDROITIN SULFATE, GLUCOSAMINE SULFATE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE SULFATE]) for Inflammation, VITAMIN D NOS, VITAMIN C [ASCORBIC ACID] and BIOTIN for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced INDURATION (Hard at top of the arm), ABSCESS (Round welch), PERIPHERAL SWELLING (Swollen top of the arm), VACCINATION SITE PRURITUS (itching really bad at the site/Slight itchy after day 1) and PYREXIA (Fever). The patient was treated with CEPHALEXIN [CEFALEXIN] at a dose of 500 mg. In June 2021, INDURATION (Hard at top of the arm), ABSCESS (Round welch), PERIPHERAL SWELLING (Swollen top of the arm), VACCINATION SITE PRURITUS (itching really bad at the site/Slight itchy after day 1) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information included Anti-itch cream.   This case was linked to MOD-2021-259228 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Outcome of event ,treatment detail, Vaccine information, Concomitant medication and Patient allergies  updated
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Acne, Hypersensitivity, Pruritus
Clinical narrative: Allergic reaction; Itchy; Breaking out all over the body; This spontaneous case was reported by a consumer and describes the occurrence of ACNE (Breaking out all over the body), HYPERSENSITIVITY (Allergic reaction) and PRURITUS (Itchy) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced ACNE (Breaking out all over the body). On 27-May-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction) and PRURITUS (Itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itchy and Acne aggravated, at a dose of 1 dosage form. At the time of the report, ACNE (Breaking out all over the body), HYPERSENSITIVITY (Allergic reaction) and PRURITUS (Itchy) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant product use was not provided.   This case was linked to MOD-2021-207609 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Fatigue, Insomnia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Crying out of pain), INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain) and MYALGIA (Muscle pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history information was reported. On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN (Crying out of pain). The patient was treated with ACETAMINOPHEN for Pain, at a dose of 500 milligram twice a day and IBUPROFEN for Pain, at a dose of 800 milligram as necessary. At the time of the report, PAIN (Crying out of pain), INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) outcome was unknown and CHILLS (Chills) and NAUSEA (Nausea) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient wished that she could never got this vaccine. Patient  went to saw the doctor and he told that it was a pinch nerve. Concomitant product included high blood pressure medicine, medicine for diabetes and medicine for cholesterol.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Crying out of pain), INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain) and MYALGIA (Muscle pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046B21A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history information was reported. On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue). On an unknown date, the patient experienced PAIN (Crying out of pain). The patient was treated with ACETAMINOPHEN for Pain, at a dose of 500 milligram twice a day and IBUPROFEN for Pain, at a dose of 800 milligram as necessary. At the time of the report, PAIN (Crying out of pain), INSOMNIA (Terrible pain at night that I cant even sleep), PAIN IN EXTREMITY (Leg pain), BACK PAIN (Back pain), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) outcome was unknown and CHILLS (Chills) and NAUSEA (Nausea) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient wished that she could never got this vaccine. Patient  went to saw the doctor and he told that it was a pinch nerve. Concomitant product included high blood pressure medicine, medicine for diabetes and medicine for cholesterol.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Fatigue, Insomnia, Magnetic resonance imaging
Clinical narrative: insomnia,sleep problems,can not sleep; "felt tired"; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (insomnia,sleep problems,can not sleep) and FATIGUE ("felt tired") in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 015M20A) for COVID-19 vaccination.     No medical history were reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced FATIGUE ("felt tired"). On an unknown date, the patient experienced INSOMNIA (insomnia,sleep problems,can not sleep). The patient was treated with TEMAZEPAM at an unspecified dose and frequency; LORAZEPAM (ATIVAN) at an unspecified dose and frequency; HALOPERIDOL (HALDOL [HALOPERIDOL]) at an unspecified dose and frequency; FAMCICLOVIR for Shingles, at an unspecified dose and frequency and PREDNISONE for Shingles, at a dose of 5 milligram. On 26-Mar-2021, FATIGUE ("felt tired") had resolved. At the time of the report, INSOMNIA (insomnia,sleep problems,can not sleep) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: normal CT scan was fine. On an unknown date, Magnetic resonance imaging: waiting for results.         No concomitant medication was mentioned.
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching
Clinical narrative: A pulsing movement near our thumb; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TWITCHING (A pulsing movement near our thumb) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE TWITCHING (A pulsing movement near our thumb). At the time of the report, MUSCLE TWITCHING (A pulsing movement near our thumb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment details were provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Product dose omission issue, Sciatica
Clinical narrative: 2nd dose > 42 days after 1st dose administered; Sciatic nerve pain; Pain in the hip area; Very excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered), PAIN (Very excruciating pain), SCIATICA (Sciatic nerve pain) and ARTHRALGIA (Pain in the hip area) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN (Very excruciating pain) and ARTHRALGIA (Pain in the hip area). In May 2021, the patient experienced SCIATICA (Sciatic nerve pain). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered). The patient was treated with GABAPENTIN at an unspecified dose and frequency. On 12-Apr-2021, PAIN (Very excruciating pain) and ARTHRALGIA (Pain in the hip area) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose > 42 days after 1st dose administered) and SCIATICA (Sciatic nerve pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided
Sex: U
Vaccine: COVID19
Symptoms: Heart rate, Vomiting
Clinical narrative: Had a vomit; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Had a vomit) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (Had a vomit). At the time of the report, VOMITING (Had a vomit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate (72-Unknown per minute): >100 per minute High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary pain
Clinical narrative: pain in his lungs / lungs are heading; This spontaneous case was reported by a non-health professional and describes the occurrence of PULMONARY PAIN (pain in his lungs / lungs are heading) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PULMONARY PAIN (pain in his lungs / lungs are heading). At the time of the report, PULMONARY PAIN (pain in his lungs / lungs are heading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Where I got the shot started itching; Is now red; Is now swollen; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Where I got the shot started itching), VACCINATION SITE ERYTHEMA (Is now red) and VACCINATION SITE SWELLING (Is now swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Where I got the shot started itching), VACCINATION SITE ERYTHEMA (Is now red) and VACCINATION SITE SWELLING (Is now swollen). At the time of the report, VACCINATION SITE PRURITUS (Where I got the shot started itching), VACCINATION SITE ERYTHEMA (Is now red) and VACCINATION SITE SWELLING (Is now swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: My arm where I got the vaccine is red; My arm where I got the vaccine swollen; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (My arm where I got the vaccine is red) and VACCINATION SITE SWELLING (My arm where I got the vaccine swollen) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (My arm where I got the vaccine is red) and VACCINATION SITE SWELLING (My arm where I got the vaccine swollen). At the time of the report, VACCINATION SITE ERYTHEMA (My arm where I got the vaccine is red) and VACCINATION SITE SWELLING (My arm where I got the vaccine swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Heart rate, Nausea
Clinical narrative: Chest pains; Problems breathing; Fever; Chills; Nausea; This spontaneous case was reported by a pharmacist and describes the occurrence of CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). On 26-May-2021, CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing) and NAUSEA (Nausea) had resolved. At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-May-2021, Heart rate: 120bpm (High) Pulse rate increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product details was not reported. Treatment details was not reported . The reporter stated that the patient called the ambulance and was taken to the emergency room for further evaluations.The paramedics stated that he told the patient that he did not have a heart attack and  after examining, the patient was released to return home.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Non-significant TCR Follow-up received.Fax number added. On 28-Jul-2021: Follow-up received contains significant information. The reporter details were updated. New event added. The outcome of some events updated from unknown to recovered/resolved.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chest pains; Problems breathing; Fever; Chills; Nausea; This spontaneous case was reported by a pharmacist and describes the occurrence of CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). On 26-May-2021, CHEST PAIN (Chest pains), DYSPNOEA (Problems breathing) and NAUSEA (Nausea) had resolved. At the time of the report, PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-May-2021, Heart rate: 120bpm (High) Pulse rate increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product details was not reported. Treatment details was not reported . The reporter stated that the patient called the ambulance and was taken to the emergency room for further evaluations.The paramedics stated that he told the patient that he did not have a heart attack and  after examining, the patient was released to return home.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Non-significant TCR Follow-up received.Fax number added. On 28-Jul-2021: Follow-up received contains significant information. The reporter details were updated. New event added. The outcome of some events updated from unknown to recovered/resolved.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Swollen glands; Fever; Muscle aches; Tiredness; Injection site pain; Injection site rash; injection site swelling; Injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching), LYMPHADENOPATHY (Swollen glands), PYREXIA (Fever), MYALGIA (Muscle aches) and FATIGUE (Tiredness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ASCORBIC ACID (ESTER C [ASCORBIC ACID]) and MAGNESIUM GLYCINATE for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Injection site rash) and VACCINATION SITE SWELLING (injection site swelling). On 28-Apr-2021, the patient experienced PYREXIA (Fever), MYALGIA (Muscle aches), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection site pain). On 30-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen glands). On 08-Apr-2021, VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Injection site rash) and VACCINATION SITE SWELLING (injection site swelling) had resolved. On 30-Apr-2021, PYREXIA (Fever), MYALGIA (Muscle aches), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection site pain) had resolved. On 04-May-2021, LYMPHADENOPATHY (Swollen glands) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (High) 100.1.         Patient had developed round rash at injection site, mild swelling, mild itching after receiving of first dose of moderna vaccine. After receiving second dose patient developed swollen glands in lower right side of neck which is at the same side as the injection.  Patient other concomitant medications include vitamins and omega fish oil 640mg oral. No treatment information was provided.   This case was linked to MOD-2021-069698 (Patient Link).   Reporter did not allow further contact
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Swollen glands; Fever; Muscle aches; Tiredness; Injection site pain; Injection site rash; injection site swelling; Injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching), LYMPHADENOPATHY (Swollen glands), PYREXIA (Fever), MYALGIA (Muscle aches) and FATIGUE (Tiredness) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ASCORBIC ACID (ESTER C [ASCORBIC ACID]) and MAGNESIUM GLYCINATE for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Injection site rash) and VACCINATION SITE SWELLING (injection site swelling). On 28-Apr-2021, the patient experienced PYREXIA (Fever), MYALGIA (Muscle aches), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection site pain). On 30-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen glands). On 08-Apr-2021, VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Injection site rash) and VACCINATION SITE SWELLING (injection site swelling) had resolved. On 30-Apr-2021, PYREXIA (Fever), MYALGIA (Muscle aches), FATIGUE (Tiredness) and VACCINATION SITE PAIN (Injection site pain) had resolved. On 04-May-2021, LYMPHADENOPATHY (Swollen glands) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (High) 100.1.         Patient had developed round rash at injection site, mild swelling, mild itching after receiving of first dose of moderna vaccine. After receiving second dose patient developed swollen glands in lower right side of neck which is at the same side as the injection.  Patient other concomitant medications include vitamins and omega fish oil 640mg oral. No treatment information was provided.   This case was linked to MOD-2021-069698 (Patient Link).   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Memory impairment
Clinical narrative: Forgetful; Very tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Very tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Very tired). At the time of the report, MEMORY IMPAIRMENT (Forgetful) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Cough, Fluid retention, Hypoaesthesia
Clinical narrative: felt like someone was taking a knife to his back; water build up in legs; Migraine; Cough; swelling of the throat; stuffy nose; temperature of 104.3F; small rash on left leg; right arm went numb/ both legs went numb/ back went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine) and COUGH (Cough) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb). On 03-Jun-2021, the patient experienced RASH (small rash on left leg). On an unknown date, the patient experienced BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose) and PYREXIA (temperature of 104.3F). At the time of the report, HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose), RASH (small rash on left leg) and PYREXIA (temperature of 104.3F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.3 (High) 104.3 F.     No concomitant medication was reported. Treatment medication was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Nasal congestion, Pharyngeal swelling, Pyrexia, Rash
Clinical narrative: felt like someone was taking a knife to his back; water build up in legs; Migraine; Cough; swelling of the throat; stuffy nose; temperature of 104.3F; small rash on left leg; right arm went numb/ both legs went numb/ back went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine) and COUGH (Cough) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 023C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb). On 03-Jun-2021, the patient experienced RASH (small rash on left leg). On an unknown date, the patient experienced BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose) and PYREXIA (temperature of 104.3F). At the time of the report, HYPOAESTHESIA (right arm went numb/ both legs went numb/ back went numb), BACK PAIN (felt like someone was taking a knife to his back), FLUID RETENTION (water build up in legs), MIGRAINE (Migraine), COUGH (Cough), PHARYNGEAL SWELLING (swelling of the throat), NASAL CONGESTION (stuffy nose), RASH (small rash on left leg) and PYREXIA (temperature of 104.3F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.3 (High) 104.3 F.     No concomitant medication was reported. Treatment medication was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Eating disorder, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of EATING DISORDER (Cannot eat or drink anything) and VOMITING (Throwing up twice) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EATING DISORDER (Cannot eat or drink anything) and VOMITING (Throwing up twice). At the time of the report, EATING DISORDER (Cannot eat or drink anything) and VOMITING (Throwing up twice) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not applicable.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Therapeutic response unexpected, Vaccination site pain
Clinical narrative: Improvement of Parkinson's symptoms after second dose; Fever; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Improvement of Parkinson's symptoms after second dose), PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Parkinson's disease since 2007. Concomitant products included VITAMINS NOS for Memory impairment, CARBIDOPA and LEVODOPA for Parkinson's disease, GABAPENTIN for an unknown indication.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm). On 24-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Improvement of Parkinson's symptoms after second dose). On 23-Apr-2021, PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm) had resolved. On 25-Apr-2021, THERAPEUTIC RESPONSE UNEXPECTED (Improvement of Parkinson's symptoms after second dose) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-207601 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up contains  On 26-Jul-2021: Follow up contains
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown.            No treatment drugs provided.  No concomitant drugs provided.  Action taken with respect to product mRNA-1273 was  not applicable.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Influenza like illness, Nasal congestion, Rash, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), COUGH (slight cough), INFLUENZA LIKE ILLNESS (flu-like symptoms lasting 2 days), RASH (rash over stomach) and VACCINATION SITE PAIN (soreness in upper arm,) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. No Medical History information was reported. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, the patient experienced NASAL CONGESTION (nasal congestion), COUGH (slight cough), INFLUENZA LIKE ILLNESS (flu-like symptoms lasting 2 days), RASH (rash over stomach) and VACCINATION SITE PAIN (soreness in upper arm,). The patient was treated with VITAMIN C [ASCORBIC ACID] at a dose of UNK dosage form. On 24-May-2021, NASAL CONGESTION (nasal congestion), COUGH (slight cough), INFLUENZA LIKE ILLNESS (flu-like symptoms lasting 2 days), RASH (rash over stomach) and VACCINATION SITE PAIN (soreness in upper arm,) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication information includes blood pressure medication,cholesterol medication and muscle spasms; for which details were not provided. Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Non significant Followup - Caller hang up the call
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: can a patient get her 2nd dose outside the 42 days interval after the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (can a patient get her 2nd dose outside the 42 days interval after the 1st dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (can a patient get her 2nd dose outside the 42 days interval after the 1st dose). On 26-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (can a patient get her 2nd dose outside the 42 days interval after the 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Vaccination site pain
Clinical narrative: upper muscle pain; joint pain; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (upper muscle pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (soreness at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced MYALGIA (upper muscle pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (soreness at injection site). At the time of the report, MYALGIA (upper muscle pain), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications are reported.  The treatment information was  not provided.